- Oral presentation
- Open Access
Prognostic significance of infarct core pathology in ST-elevation myocardial infarction survivors revealed by quantitative T2-weighted cardiac magnetic resonance
© Carrick et al; licensee BioMed Central Ltd. 2015
- Published: 3 February 2015
- Cardiac Magnetic Resonance
- Late Gadolinium Enhancement
- STEMI Patient
- Microvascular Obstruction
- Heart Failure Hospitalization
Myocardial transverse relaxation time (T2, ms) is a fundamental magnetic property of tissue that is related to water content and mobility. The pathophysiological and prognostic importance of native myocardial T2 in acute ST-elevation myocardial infarction (STEMI) patients is unknown. We aimed to assess the clinical significance of native T2 within the infarct core using cardiac magnetic resonance (CMR) imaging.
We performed a prospective single center cohort study in reperfused STEMI patients who underwent CMR 2 days and 6 months post-MI. T2-weighted CMR (investigational prototype T2-prepared TrueFisp sequence) was measured in myocardial regions-of-interest. The infarct territory and microvascular obstruction were depicted with late gadolinium enhancement CMR. All-cause death or heart failure hospitalization was a pre-specified outcome that was assessed during follow-up.
324 STEMI patients (mean±SD age 59±12 years, 237 males, 121 with anterior STEMI) gave informed consent and had CMR (14 July 2011 - 22 November 2012). All 324 had follow-up assessments (median duration 860 days). Infarct size was 18 ±14% of LV mass. One hundred and sixty four (51%) patients had late microvascular obstruction whereas 197 (61%) patients had an infarct core revealed by native T2. Native T2 within the infarct core (53.9±4.8) was higher than in the remote zone (49.7±2.1 ms; p<0.01) but lower than in the area-at-risk (62.9±5.1 ms) (p<0.01). In multivariable linear regression, native T2 in the infarct core was negatively associated with heart rate, Killip class, and peak neutrophil count at presentation (all p<0.05).
Baseline T2 core (ms) was univariably associated with LVEF (0.31 (0.04, 0.58); p=0.023). Baseline T2 core was not associated with LVEF or volumes at 6 months.
Thirty (10.4%) patients died or experienced a heart failure event. These events included 5 cardiovascular deaths, 3 non-cardiovascular deaths and 22 episodes of heart failure (Killip Class 3 or 4 heart failure (n=20) or defibrillator implantation n=2). T2-core (ms) was associated with all-cause death or heart failure hospitalization (hazard ratio 0.786, 95% CI 0.658, 0.939; p=0.008) including after adjustment for LVEF at baseline (p=0.017) or LV end-diastolic volume at baseline (p=0.009).
Infarct core revealed by native T2 was common and independently associated with all-cause death or heart failure hospitalization post-discharge.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.